| Literature DB >> 23936191 |
Corinna Montrone1, Konstantinos D Kokkaliaris, Dirk Loeffler, Martin Lechner, Gabi Kastenmüller, Timm Schroeder, Andreas Ruepp.
Abstract
HSC-Explorer (http://mips.helmholtz-muenchen.de/HSC/) is a publicly available, integrative database containing detailed information about the early steps of hematopoiesis. The resource aims at providing fast and easy access to relevant information, in particular to the complex network of interacting cell types and molecules, from the wealth of publications in the field through visualization interfaces. It provides structured information on more than 7000 experimentally validated interactions between molecules, bioprocesses and environmental factors. Information is manually derived by critical reading of the scientific literature from expert annotators. Hematopoiesis-relevant interactions are accompanied with context information such as model organisms and experimental methods for enabling assessment of reliability and relevance of experimental results. Usage of established vocabularies facilitates downstream bioinformatics applications and to convert the results into complex networks. Several predefined datasets (Selected topics) offer insights into stem cell behavior, the stem cell niche and signaling processes supporting hematopoietic stem cell maintenance. HSC-Explorer provides a versatile web-based resource for scientists entering the field of hematopoiesis enabling users to inspect the associated biological processes through interactive graphical presentation.Entities:
Mesh:
Year: 2013 PMID: 23936191 PMCID: PMC3728102 DOI: 10.1371/journal.pone.0070348
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Detailed curation of an interaction in HSC-Explorer.
Information about the interaction between ‘Tie2/Ang1 signaling’ and the term ‘quiescence’ consists of (a) ‘General information’ about the organism used in the experiment and reference, (b) textual information (‘Comment’) about the interaction and experimental procedure, and (c) structured information including in addition information about the hematopoietic cell-type.
Populations enriched for hematopoietic stem cells.
| Reference | Publication date | Immunophenotype | Multilineagereconstitution | Self-renewal | quiescence | Single cell |
| 2898810 | Spangrude, et al., 1988 | HSC (Thy1(lo)Sca1+Lin-) | <12 weeks | NA | yes | |
| 1281687 | Okada et al., 1992 | HSC (KSL) | >16 weeks | NA | NA | |
| 1346154 | Uchida et al., 1992 | HSC (Thy1(lo)Sca1+Lin-) | >16 weeks | NA | NA | |
| 1371359 | Ikuta et al., 1992 | HSC (Thy1(lo)KSL) | >16 weeks | NA | NA | |
| 8662508 | Osawa et al., 1996 | HSC (CD34-KSL) | >32 weeks | high | NA | yes |
| 8666936 | Goodell et al., 1996 | HSC (SP,Sca1+Lin-) | >16 weeks | NA | yes | |
| 11672547 | Adolfsson, et al., 2001 | HSC (CD135-KSL) | >16 weeks | high | NA | |
| 14738767 | Matsukaki et al.,2004 | HSC (CD34-SP(Tip),KSL) | >16 weeks | NA | NA | |
| 15989959 | Kiel et al., 2005 | HSC (CD150+CD48-CD41-KSL) | >16 weeks | high | NA | |
| HSC (CD150+CD48-CD244-) | >16 weeks | high | NA | |||
| HSC (CD150+Thy1(lo)KSL) | >16 weeks | high | NA | |||
| 18371352 | Dykstra et al., 2007 | HSCalpha (CD45(mid)lin-Rho-SP) | >16 weeks | high | NA | yes |
| HSCbeta (CD45(mid)lin-Rho-SP) | >16 weeks | high | NA | yes | ||
| HSCgamma (CD45(mid)lin-Rho-SP) | >16 weeks | NO | NA | yes | ||
| HSCdelta (CD45(mid)lin-Rho-SP) | >16 weeks | NO | NA | yes | ||
| 18055867 | Weksberg et al.,2008 | HSC (CD150+SP,KSL) | >16 weeks | high | yes | |
| HSC (CD150-SP,KSL) | >16 weeks | high | yes | |||
| 19062086 | Wilson et al., 2008 | dormant-HSC(LRC-HSC, CD34-CD150+CD48-CD135-KSL) | >16 weeks | high | yes | |
| 19377048 | Kent et al., 2009 | HSC (CD150+CD45+CD201+CD48-) | >16 weeks | high | NA | yes |
| HSC (CD150-CD45+CD201+CD48-) | >16 weeks | low | NA | yes | ||
| 20207229 | Challen et al., 1010 | My-bi-HSC (lower SP,KSL) | >16 weeks | high | yes | |
| Ly-bi-HSC (upper SP,KSL) | >16 weeks | low | yes | |||
| 20074534 | Benveniste et al., 2010 | LT-HSC (CD34(lo)CD135-Rho(lo)CD49b(lo)KSL) | >32 weeks | high | yes | |
| IT-HSC (CD34(lo)CD135-Rho(lo)CD49b(hi)KSL) | >16 weeks | low | yes | |||
| ST-HSC (CD34(hi)CD135+Rho(hi)KSL) | <12 weeks | NO | NO | |||
| 20421392 | Morita, et al., 2010 | HSC (CD150(hi)CD34-KSL) | >16 weeks | high | NA | |
| HSC (CD150(int)CD34-KSL) | >16 weeks | low | NA | |||
| HSC (CD150-CD34-KSL) | >16 weeks | NO | NA |
Bone marrow stromal cell types (endosteal) known to contribute to the hematopoietic microenvironment.
| PMID | Author | Niche cell type | Niche factor | HSC counterpart | HSC sub-type | Signaling process | Role | |
|
| 18371409 | Yoshihara et al., 2007 | Osteoblast (ALP+Thpo+) | Thrombopoietin (Thpo) | Mpl | CD34-MPL+KSL | TPO/MPL signaling | HSC self-renewal/ quiescence |
| 15260986 | Arai et al., 2004 | Osteoblast (osteocalcin+Ang1+) | Angiopoietin (Ang1) | Tek (Tie2) | Tie2+SP KSL | Tie2/Ang1 signaling | HSC adhesion/ quiescence | |
| 14574413 | Calvi et al., 2003 | Osteoblast (osteopontin+Jag1+) | Jagged 1 (Jag1) | Notch1 | KSL | Notch signaling pathway | ||
| 20887955 | Kieslinger et al., 2010 | Osteoblast (Ebf2+) | Early B cell factor 2 (Ebf2) | Sca1+ | Wnt signaling pathway | |||
| 21108988 | Jung et al., 2011 | Endosteum (Anexin2+) | Annexin 2 (Anxa2), Chemokine (C-X-C motif) ligand 12 (Cxcl12) | CD150+CD48-CD41-Lin- | CXCL12/CXCR4 signaling | HSC homing and CXCL12-driven cell migration | ||
| 22817897 | Sugimura et al., 2012 | Osteoblast (N-cadherin+) | Flamingo (Fmi)/Frizzled (Fz8) | Flamingo (Fmi)/Frizzled (Fz8) | LRC, CD135-KSL/ Fmi+Fz8+ | Non-canonical Wnt signaling / Ca2+ intracellular signaling | HSC quiescence | |
| 14574412 | Zhang et al., 2003 | Spindel shaped (N-cadherin+CD45-) osteoblastic cells | N-cadherin (Cdh2) | N-cadherin (Cdh2) | LRC/N-cad+CD45+KSL | BMP signalling | ||
| 22118468 | Yamazaki et al., 2011 | Osteoblast (osteocalcin+) | CD150+CD48-CD41-Lin- | |||||
| 21653324 | Mazzon et al., 2011 | Primary MSC-enriched cell (Alcam-Sca1+) | Agrin (Agrn) | Alpha-dystroglycan (Dag1) | CD34+CD135-KSL | Ras signaling | HSC apoptosis | |
| 21868569 | Arcangeli et al., 2011 | Stromal cell (JamB+) | Junction adhesion molecule 3 (JamC) | Junction adhesion molecule 2 (JamB) | CD150+CD48-CD41-Lin- | HSC adhesion | ||
| 21131587 | Lymperi et al., 2011 | Osteoclast | CD135-KSL | HSC quiescence | ||||
| 19062086 | Wilson et al., 2008 | Endosteum | LRC, Kit+ | HSC quiescence | ||||
| 20703299 | Méndez-Ferrer et al., 2010 | MSC (Nestin+) | CD150+CD48-Lin- | HSC homing | ||||
| 20713966 | Winkler et al., 2010 | Osteomac (F4/80+Ly6G-CD11b+) | CD150+CD48-KSL | HSC mobilization | ||||
| 19516257 | Naveiras et al., 2009 | Adipocyte | CD135-KSL | HSC quiescence |
Bone marrow stromal cell types (vascular/endothelial) known to contribute to the hematopoietic microenvironment.
| PMID | Author | Niche cell type | Niche factor | HSC counterpart | HSC sub-type | Signaling process | Role | |
|
| 19797522 | Lewandowski et al., 2010 | Vascular endothelial cell (Pecam1+) | Vascular cell adhesion molecule 1 (Vcam1) | CFSE-labeled CD34-KSL | |||
| 15989959 | Kiel et al., 2005 | Sinusoidal endothelium (MECA-32+) | CD150+CD48-CD41-Lin- | |||||
| 17174120 | Sugiyama et al., 2006 | CAR cells (Cxcl12+) | C-X-C motif ligand 12 (Cxcl12) | C-X-C chemokine receptor type 4 (Cxcr4) | Sca1+cKit+/CD150+CD48-CD41- | CXCL12/CXCR4 signaling | HSC quiescence | |
| 20207228 | Butler et al., 2010 | Sinusoidal endothelium (VE-cadherin+) | Jagged | Notch | TNR.GFP+ | Notch signaling pathway | ||
| 22118468 | Yamazaki et al., 2011 | Sinusoidal endothelium (VE-cadherin+) | CD150+CD48-CD41-Lin- | |||||
| 22281595 | Ding et al., 2012 | Sinusoidal endothelium | Stem cell factor (SCF,Kitl) | Kit oncogene (c-Kit) | CD150+CD48-Lin- | HSC maintenance | ||
| 22118468 | Yamazaki et al., 2011 | Non-myelinated Schwann cell (GFAP+) | Integrin beta 8 (Itgb8) | Tgf-beta receptor | CD150+CD48-CD41-Lin- | Tgf-beta/SMAD signaling | HSC quiescence | |
| 20703299 | Méndez-Ferrer et al., 2010 | MSC (Nestin+) | CD150+CD48-Lin- | HSC homing | ||||
| 22281595 | Ding et al., 2012 | Perivascular cell (Lepr+) | Stem cell factor (SCF,Kitl) | Kit oncogene (c-Kit) | CD150+CD48-Lin- | HSC maintenance | ||
| 22983360 | Ludin et al., 2011 | Monocytes-macrophage (alpha-SMA+) | Prostaglandin-endoperoxide synthase 2 (Ptgs2, Cox2), C-X-C motif ligand 12 (Cxcl12) | C-X-C chemokine receptor type 4 (Cxcr4) | CD150+CD48-CD41- | ROS signaling/CXCL12/CXCR4 signaling | HSC maintenance | |
| 21282381 | Chow et al., 2011 | Macrophage (CD169+)+MSC (Nes+) | C-X-C motif ligand 12 (Cxcl12) | C-X-C chemokine receptor type 4 (Cxcr4) | CD135-KSL | CXCL12/CXCR4 signaling | HSC adhesion/mobilization | |
| 21115812 | de Graaf et al., 2010 | Megakaryocyte | Thyroid peroxidase (Tpo) | Myeloproliferative leukemia virus oncogene (Mpl) | CD34-CD135-KSL | TPO/MPL signaling |
Figure 2Graphical presentation of the ‘Cxcl12/Cxcr4 signaling’ network.
The graph illustrates the process of Cxcl12/Cxcr4 signaling (described in the text) based on the interactions between heterogeneous factors such as proteins (beige), bioprocesses (orange), chemical compounds (green), niche cell types (cyan), hematopoietic stem/progenitor cells (light blue) and a microRNA (purple).
Figure 3Influence of the subunit composition of PRC1 on the fate of hematopoietic stem cells.
The subunit composition of the polycomb repressive complex (PRC1) is responsible for the balance between self-renewal and differentiation of hematopoietic stem cells. Cbx7 and Cbx8 compete for integration into the PRC1 complex. While Cbx7 inhibits HSC differentiation and induces self-renewal, Cbx8 has the opposite effect. Interaction types indicate ‘is part of’ (red arrow), ‘increase activity’ (green arrow), ‘affects activity’ (open green arrow), ‘increase expression’ (black arrow) and ‘interacts’ (red line). T-bar arrows indicate inhibitory behaviour.